SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-088492
Filing Date
2024-04-05
Accepted
2024-04-05 16:20:03
Documents
14
Period of Report
2024-04-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d805485d8k.htm   iXBRL 8-K 29246
2 EX-3.1 d805485dex31.htm EX-3.1 9336
  Complete submission text file 0001193125-24-088492.txt   164891

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agen-20240403.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20240403_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20240403_pre.xml EX-101.PRE 11262
18 EXTRACTED XBRL INSTANCE DOCUMENT d805485d8k_htm.xml XML 3761
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 24826776
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)